Document is current
Any future updates will be listed below
-
Authors
Ito, Jumpei https://orcid.org/0000-0003-0440-8321
Strange, Adam
Liu, Wei https://orcid.org/0009-0008-7431-9950
Joas, Gustav https://orcid.org/0009-0003-1817-3356
Lytras, Spyros https://orcid.org/0000-0003-4202-6682
,
Matsuno, Keita
Nao, Naganori
Sawa, Hirofumi
Mizuma, Keita
Kojima, Isshu
Li, Jingshu
Tsubo, Tomoya
Tanaka, Shinya
Tsuda, Masumi
Wang, Lei
Oda, Yoshikata
Ferdous, Zannatul
Shishido, Kenji
Fukuhara, Takasuke
Tamura, Tomokazu
Suzuki, Rigel
Suzuki, Saori
Tsujino, Shuhei
Ito, Hayato
Kaku, Yu
Misawa, Naoko
Plianchaisuk, Arnon
Guo, Ziyi
Hinay, Alfredo A. Jr.
Usui, Kaoru
Saikruang, Wilaiporn
Uriu, Keiya
Kosugi, Yusuke
Fujita, Shigeru
M.Tolentino, Jarel Elgin
Chen, Luo
Pan, Lin
Li, Wenye
Suganami, Mai
Chiba, Mika
Yoshimura, Ryo
Yasuda, Kyoko
Iida, Keiko
Ohsumi, Naomi
Tanaka, Shiho
Okumura, Kaho
Yoshimura, Kazuhisa
Sadamas, Kenji
Nagashima, Mami
Asakura, Hiroyuki
Yoshida, Isao
Nakagawa, So
Takaori-Kondo, Akifumi
Shirakawa, Kotaro
Nagata, Kayoko
Nomura, Ryosuke
Horisawa, Yoshihito
Tashiro, Yusuke
Kawai, Yugo
Takayama, Kazuo
Hashimoto, Rina
Deguchi, Sayaka
Watanabe, Yukio
Nakata, Yoshitaka
Futatsusako, Hiroki
Sakamoto, Ayaka
Yasuhara, Naoko
Hashiguchi, Takao
Suzuki, Tateki
Kimura, Kanako
Sasaki, Jiei
Nakajima, Yukari
Yajima, Hisano
Irie, Takashi
Kawabata, Ryoko
Sasaki-Tabata, Kaori
Ikeda, Terumasa
Nasse, Hesham
Shimizu, Ryo
Begum, MST Monira
Jonathan, Michael
Mugita, Yuka
Leong, Sharee
Takahashi, Otowa
Ichihara, Kimiko
Ueno, Takamasa
Motozono, Chihiro
Toyoda, Mako
Saito, Akatsuki
Shofa, Maya
Shibatani, Yuki
Nishiuchi, Tomoko
Zahradni, Jiri
Andrikopoulos, Prokopios
Padilla-Blanco, Miguel
Konar, Aditi
Sato, Kei https://orcid.org/0000-0003-4431-1380
- License Information
-
More Information
Article History
Received: 18 July 2024
Accepted: 22 April 2025
First Online: 13 May 2025
Competing interests
: J.I. has consulting fees and honoraria for lectures from Takeda Pharmaceutical Co. Ltd Spyros Lytras has consulting fees from EcoHealth Alliance. K.S. has consulting fees from Moderna Japan Co., Ltd and Takeda Pharmaceutical Co. Ltd, and honoraria for lectures from Gilead Sciences, Inc., Moderna Japan Co., Ltd, and Shionogi & Co., Ltd. The other authors declare no competing interests.
